Docking Studies on HIV Integrase Inhibitors Based On Potential Ligand Binding Sites
Published Article.!!!!!
International Journal on Bioinformatics & Biosciences (IJBB)
ISSN : 1839-9614
Webpage URL; https://wireilla.com/ijbb/index.html
Paper Title;
Docking Studies on HIV Integrase Inhibitors Based On Potential Ligand Binding Sites
Authors;
Subhomoi Borkotoky*
ABSTRACT
HIV integrase is a 32 kDa protein produced from the C-terminal portion of the Pol gene product, and is
an attractive target for new anti-HIV drugs. Integrase is an enzyme produced by a retrovirus (such as
HIV) that enables its genetic material to be integrated into the DNA of the infected cell. Raltegravir and
Elvitegravir are two important drugs against integrase.
KEYWORDS
Integrase, Chemsketch, Virtual screening
Contact us; ijbbjournal@wireilla.com (or) ijbbjournal@yahoo.com
Volume URL; https://wireilla.com/ijbb/vol2.html
PDF URL; https://wireilla.com/papers/ijbb/V2N3/2312ijbb03.pdf

Comments
Post a Comment